Hristov & Partners has advised on the MTD Bulgaria Restructuring

Hristov & Partners, alongside with the global counsel, has advised MTD Products Inc., with headquarters in Cleveland. Ohio, the leading manufacturer of outdoor power and lawn care equipment, on the restructuring of its business operation in Bulgaria. The restructuring was based on business review and included among others voluntary liquidation of the Bulgarian subsidiary company […]

Hristov & Partners Advised Impala Invest and Bella Bulgaria on the Acquisition of Creta Farms

Hristov & Partners advised the acquirer on certain aspects of the transaction documents for the purchase of assets and production facilities of one of the leading producers of processed foods in Greece Creta Farms. Impala Invest Group stated that “this is the biggest foreign (outbound) investment by a Bulgarian food company”. Our firm’s team was […]

Bulgarian competition authority’s prohibition of the sale of CEZ assets in Bulgaria annulled by the court

On 22 July 2020 the Sofia Region Administrative Court annulled the Bulgarian Commission for Protection of Competition’s decision from 2019 prohibiting the acquisition of Czech utility CEZ’ assets in Bulgaria by the financial and insurance group Eurohold Bulgaria. The court found that the Commission had committed severe procedural violations depriving the parties from their right […]

The latest abuse of stronger bargaining position case in Bulgaria: Fast Pay vs CEZ

On 11 June 2020 the Commission for Protection of Competition (CPC or the Commission) adopted Decision No. 466/11/06.2020 (the Decision) imposing fines in a total amount of c. BGN 4,410,000 (c. EUR 2,250,000) on CEZ Bulgaria, CEZ Electro Bulgaria and CEZ Razpredelenie Bulgaria (collectively CEZ) for abuse of a stronger bargaining position under Art. 37a […]

Fantastic Results in Legal 500 EMEA 2020

We are very pleased to share our firm’s greatest recognition and highest rankings to date in the new 2020 edition of the leading international legal directory Legal 500 EMEA. Hristov & Partners is ranked in Tier 2 in both categories where we compete: Commercial, Corporate and M&A and EU and Competition. Like in the previous […]

The ECJ’s ruling in Case C-307/18 (Paroxetine) – important insights for the pharma sector and antitrust in general

On 30 January 2020 the ECJ issued its preliminary ruling in Case C-307/18 which is likely to have both general and sector-specific implications for antitrust practice. The case concerns certain pay-for-delay agreements between GSK as the manufacturer of an originator drug called paroxetine and its (potential) generic competitors on the UK market IVAX, GUK and […]